Publications
Explore 1,788 academic publications
Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis
Background The coronavirus disease 2019 (COVID-19) outbreak is evolving rapidly worldwide. Objective To evaluate the risk of serious adverse outcomes in patients with COVID-19 b...
An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics
For a decade, The Cancer Genome Atlas (TCGA) program collected clinicopathologic annotation data along with multi-platform molecular profiles of more than 11,000 human tumors ac...
The illusion of control.
While most people will agree that there is much overlap between skill and luck, a full understanding of how inextricably bound the two are has yet to be attained. In principle t...
Haemodynamic definitions and updated clinical classification of pulmonary hypertension
Since the 1st World Symposium on Pulmonary Hypertension (WSPH) in 1973, pulmonary hypertension (PH) has been arbitrarily defined as mean pulmonary arterial pressure (mPAP) ≥25 m...
Atezolizumab for First-Line Treatment of Metastatic Nonsquamous NSCLC
The addition of atezolizumab to bevacizumab plus chemotherapy significantly improved progression-free survival and overall survival among patients with metastatic nonsquamous NS...
Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study
Abstract Objective To characterise the clinical features of patients admitted to hospital with coronavirus disease 2019 (covid-19) in the United Kingdom during the growth phase ...
Guidelines on the management of valvular heart disease (version 2012)
linea guida per la pratica clinica
Assessment of Clinical Criteria for Sepsis
Among ICU encounters with suspected infection, the predictive validity for in-hospital mortality of SOFA was not significantly different than the more complex LODS but was stati...
Pembrolizumab plus Chemotherapy for Squamous Non–Small-Cell Lung Cancer
In patients with previously untreated metastatic, squamous NSCLC, the addition of pembrolizumab to chemotherapy with carboplatin plus paclitaxel or nab-paclitaxel resulted in si...